These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 18617873)
1. Varenicline (Chantix) warnings: risk versus benefit. Med Lett Drugs Ther; 2008 Jul; 50(1290):53. PubMed ID: 18617873 [No Abstract] [Full Text] [Related]
2. Possible varenicline-induced paranoia and irritability in a patient with major depressive disorder, borderline personality disorder, and methamphetamine abuse in remission. Lyon GJ J Clin Psychopharmacol; 2008 Dec; 28(6):720-1. PubMed ID: 19011454 [No Abstract] [Full Text] [Related]
3. Treatment of nicotine dependence with Chantix (varenicline). Rankin KV; Jones DL Tex Dent J; 2011 May; 128(5):457-61. PubMed ID: 21834368 [TBL] [Abstract][Full Text] [Related]
4. Varenicline for tobacco dependence. Tavares AR N Engl J Med; 2009 Feb; 360(7):731. PubMed ID: 19222131 [No Abstract] [Full Text] [Related]
10. Smoking cessation and varenicline. Do not expose or re-expose patients to its serious adverse effects! Prescrire Int; 2014 Sep; 23(152):208. PubMed ID: 25325119 [No Abstract] [Full Text] [Related]
12. A double-blind randomized placebo-controlled pilot study of neuropsychiatric adverse events in abstinent smokers treated with varenicline or placebo. Garza D; Murphy M; Tseng LJ; Riordan HJ; Chatterjee A Biol Psychiatry; 2011 Jun; 69(11):1075-82. PubMed ID: 21295286 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation. Oncken C; Gonzales D; Nides M; Rennard S; Watsky E; Billing CB; Anziano R; Reeves K Arch Intern Med; 2006 Aug 14-28; 166(15):1571-7. PubMed ID: 16908789 [TBL] [Abstract][Full Text] [Related]